Review of Chronic Graft-Versus-Host Disease in Children After Allogeneic Stem Cell Transplantation: Nursing Perspective

Journal of Pediatric Oncology Nursing

Volumn 28, Issue 1, 2011, Pages 6-15

  Liu, Ying Mei ^a   Hockenberry, Marilyn ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Children; Chronic graft versus host disease; Incidence; Risk factors

Indexed keywords

EID: 79953310528     PISSN: 10434542     EISSN: 15328457     Source Type: Journal    
DOI: 10.1177/1043454210377177     Document Type: Review

References (48)

1. Bishop, M. R. (2009). Hematopoietic stem cell transplantation. New York, NY: Springer.
2. Bradley, M. B., Satwani, P., Baldinger, L., Morris, E., van de Ven, C., Del Toro, G.,... Cairo, M. S. (2007). Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplantation, 40, 621-631.
3. Carlens, S., Ringden, O., Remberger, M., Lonnqvist, B., Hagglund, H., Klaesson, S.,... Aschan, J. (1998). Risk factors for chronic graft-versus-host disease after bone marrow transplantation: A retrospective single centre analysis. Bone Marrow Transplantation, 22, 755-761.
4. Couriel, D. R. (2008). Ancillary and supportive care in chronic graft-versus-host disease. Best Practice & Research Clinical Haematology, 21, 291-307.
5. Couriel, D., Carpenter, P. A., Cutler, C., Bolanos-Meade, J., Treister, N. S., Gea-Banacloche, J.,... Flowers, M. E. (2006). Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation, 12, 375-396.
6. Cutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A., & Antin, J. H. (2001). Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis. Journal of Clinical Oncology, 19, 3685-3691.
7. Eapen, M., Horowitz, M. M., Klein, J. P., Champlin, R. E., Loberiza, F. R., Jr., Ringden, O., Wagner, J. E. (2004). Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Journal of Clinical Oncology, 22, 4872-4880.
8. Fagioli, F., Zecca, M., Locatelli, F., Lanino, E., Uderzo, C., Di Bartolomeo, P.,... AIEOP-HSCT Group. (2008). Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission. Journal of Pediatric Hematology/Oncology, 30, 575-583.
9. Falkenburg, J. H., van de Corput, L., Marijt, E. W., & Willemze, R. (2003). Minor histocompatibility antigens in human stem cell transplantation. Experimental Hematology, 31, 743-751.
10. Ferrara, J. L. M., Levine, J. E., Reddy, P., & Holler, E. (2009). Graft-versus-host disease. Lancet, 373, 1495-1576.
11. Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J.,... Flowers, M. E. (2005). National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation, 11, 945-956.
12. Higman, M. A., & Vogelsang, G. B. (2004). Chronic graft versus host disease. British Journal of Haematology, 125, 435-454.
13. Hollander, G. A., Widmer, B., & Burakoff, S. J. (1994). Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. Journal of Immunology, 152, 1609-1617.
14. Huang, X., Liu, D., Liu, K., Xu, L., Chen, H., Han, W.,... Zhang, X. (2009). Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematologic malignancies in children. Biology of Blood and Marrow Transplantation, 15, 91-94.
15. Iravani, M., Mousavi, A., Gholibeikian, S., Bahar, B., Samiee, S., Ashouri, A.,... Ghavamzadeh, A. (2005). Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation. Bone Marrow Transplantation, 35, 1095-1099.
16. Jagasia, M., Giglia, J., Chinratanalab, W., Dixon, S., Chen, H., Frangoul, H.,... Schuening, F. (2007). Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biology of Blood and Marrow Transplantation, 13, 1207-1215.
17. Joseph, R. W., Couriel, D. R., & Komanduri, K. V. (2008). Chronic graft-versus-host disease after allogeneic stem cell transplantation: Challenges in prevention, science, and supportive care. Journal of Supportive Oncology, 6, 361-372.
18. Kansu, E. (2004). The pathophysiology of chronic graft-versus-host disease. International Journal of Hematology, 79, 209-215.
19. Kolb, H. J., Schattenberg, A., Goldman, J. M., Hertenstein, B., Jacobsen, N., Arcese, W.,... European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. (1995). Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86, 2041-2050.
20. Kondo, M., Kojima, S., Horibe, K., Kato, K., & Matsuyama, T. (2001). Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children. Bone Marrow Transplantation, 27, 727-730.
21. Kruger, W. H., Bohlius, J., Cornely, O. A., Einsele, H., Hebart, H., Massenkeil, G.,... Wolf, H. (2005). Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the German Society of Haematology and Oncology. Annals of Oncology, 16, 1381-1390.
22. Kurtzberg, J. (2009). Update on umbilical cord blood transplantation. Current Opinion in Pediatrics, 21, 22-29.
23. Kurtzberg, J., Prasad, V. K., Carter, S. L., Wagner, J. E., Baxter-Lowe, L. A., Wall, D.,... COBLT Steering Committee. (2008). Results of the Cord Blood Transplantation Study (COBLT): Clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112, 4318-4327.
24. Lee, S. J., & Flowers, M. E. (2008). Recognizing and managing chronic graft-versus-host disease. Hematology, 134-141.
25. Lee, S. J., Joffe, S., Artz, A. S., Champlin, R. E., Davies, S. M., Jagasia, M.,... Eapen, M. (2008). Individual physician practice variation in hematopoietic cell transplantation. Journal of Clinical Oncology, 26, 2162-2170.
26. Lee, S. J., Vogelsang, G., & Flowers, M. E. D. (2003). Chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 9, 215-233.
27. Leiper, A. D. (2002). Non-endocrine late complications of bone marrow transplantation in childhood: Part I. British Journal of Haematology, 118, 3-22.
28. Madero, L., Gonzalez Vicent, M., Ramirez, M., Quintero, V., Benito, A., & Diaz, M. A. (2000). Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children. Bone Marrow Transplantation, 26, 269-273.
29. Madrigal, J. A., Cohen, S. B. A., Gluckman, E., & Charron, D. J. (1997). Does cord blood transplantation result in lower graftversus-host disease? It takes more than two to tango. Human Immunology, 56, 1-5.
30. Mielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M.,... Storb, R. (2003). Graftversus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood, 102, 756-762.
31. Parkman, R., & Weinberg, K. I. (2004). Immune reconstitution following hematopoietic cell transplantation. In K. G. Blume, S. J. Forman, & F. R. Appelbaum (Eds.), Thomas' hematopoietic cell transplantation (3rd ed., pp. 853-861). Oxford, UK: Blackwell Publishing.
32. Randolph, S. S. B., Gooley, T. A., Warren, E. H., Appelbaum, F. R., & Riddell, S. R. (2004). Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood, 103, 347-352.
33. Remberger, M., Beelen, D. W., Fauser, A., Basara, N., Basu, O., & Ringden, O. (2005). Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors. Blood, 105, 548-551.
34. Remberger, M., Kumlien, G., Aschan, J., Barkholt, L., Hentschke, P., Ljungman, P.,... Ringdén, O. (2002). Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8, 674-682.
35. Richards, S. J., Morgan, G. J., & Hillmen, P. (1999). Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age. Blood, 94, 2790-2799.
36. Rocha, V., Cornish, J., Sievers, E. L., Filipovich, A., Locatelli, F., Peters, C.,... Gluckman, E. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 2962-2971.
37. Rocha, V., Wagner, J. E., Sobocinski, K. A., Klein, J. P., Zhang, M. J., Horowitz, M. M.,... Gluckman, E. (2000). Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. New England Journal of Medicine, 342, 1846-1854.
38. Satwani, P., Sather, H., Ozkaynak, F., Heerema, N. A., Schultz, K. R., Sanders, J.,... Cairo, M. S. (2007). Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A Children's Oncology Group study report. Biology of Blood and Marrow Transplantation, 13, 218-227.
39. Schmitz, N., Eapen, M., Horowitz, M. M., Zhang, M. J., Klein, J. P., Rizzo, J. D.... European Group for Blood and Marrow Transplantation. (2006). Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood, 108, 42884290.
40. Sharma, V. K., Singh, U. K., Prasad, R., & Fletcher, S. (2009). Stem cell through present and future. Indian Journal of Pediatrics, 76, 5156.
41. Strahm, B., Locatelli, F., Bader, P., Ehlert, K., Kremens, B., Zintl, F., ... Niemeyer, C. M (2007). Reduced intensity conditioning in unrelated donor transplantation for refrac tory cytopenia in childhood. Bone Marrow Transplantation, 40, 329-333.
42. Takatsuka, H., Iwasaki, T., Okamoto, T., & Kakishita, E. (2003). Intestinal graftversushost disease: Mechanisms and management. Drugs, 63, 115.
43. Thomson, B. G., Robertson, K. A., Gowan, D., Heilman, D., Broxmeyer, H. E., Emanuel, D., ... Smith, F. O. (2000). Analysis of engraftment, graftversushost disease, and immune recovery following unrelated donor cord blood transplantation. Blood, 96, 2703-2711.
44. Viale, P. H. (2006). Chemotherapy and cutaneous toxicities: Implications for oncology nurses. Seminars in Oncology Nurs- ing, 22, 144-151.
45. Wall, D. A., Carter, S. L., Kernan, N. A., Kapoor, N., Kamani, N. R., Brochstein, J. A., ... COBLT Steering Com mittee. (2005). Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: The Cord Blood Transplantation study (COBLT) experience. Biology of Blood and Marrow Transplantation, 11, 637-646.
46. Watanabe, N., Matsumoto, K., Yoshimi, A., Horibe, K., Matsuyama, T., Kojima, S., Kato, K. (2008). Outcome of bone marrow transplantation from HLAidentical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graftversushost dis ease. International Journal of Hematology, 88, 575-582.
47. Zecca, M., Prete, A., Rondelli, R., Lanino, E., Balduzzi, A., Messina, C., ... AIEOPBMT Group. Italian Association for Pediatric Hematology and OncologyBone Marrow Transplant. (2002). Chronic graftversushost disease in chil dren: Incidence, risk factors, and impact on outcome. Blood, 100, 1192-1200.
48. Zhang, C., Todorov, I., Zhang, Z., Liu, Y., Kandeel, F., Forman, S., ... Zeng, D. (2006). Donor CD4+ T and B cells in transplants induce chronic graftversushost disease with autoimmune manifestations. Blood, 107, 2993-3001.